Andrew Huberman
Andrew Huberman is a neuroscientist and podcast host. His published research primarily focuses on the visual system, including retinal ganglion cell injury and regeneration, visual circuits, and therapies for optic neuropathy. Additionally, his work investigates central nervous system regeneration, visually evoked threat responses, and the effects of structured respiration practices on mood and physiology.
120 claims checked on air: 17 context 7 contradicted 16 overstated 66 supported 14 unverified
What they said on air - overstated
1 citing their own research
Approximately 115 million adults in the United States have pre-diabetes.
"Right now, about 115 million adults in the US have pre-diabetes." (said at 0:18:46)
Nationally representative surveillance data from the CDC and the National Health and Nutrition Examination Survey (NHANES) estimate that approximately 98 million adults (about 38% of the adult population) in the United States have prediabetes (PMID: 41115173, PMID: 41731628), up from earlier estimates of 84 to 88 million (PMID: 31851648). The figure of 115 million overstates the number of individuals with prediabetes alone and likely conflates prediabetes with the total number of U.S. adults living with dysglycemia (diabetes and prediabetes combined).
Cold exposure induces a sustained release of dopamine and adrenaline that lasts for multiple hours.
"And yes, there's a nice long wave of dopamine that lasts many hours, that's known. There's a nice long wave of adrenaline." (said at 0:34:43)
A widely cited human trial (Šrámek et al., 2000) evaluated 1-hour cold water immersion (14°C) in young men and observed significant increases in plasma dopamine (by 250%) and noradrenaline/norepinephrine (by 530%), but plasma adrenaline (epinephrine) concentrations remained unchanged. Furthermore, an earlier study (Šrámek et al., 1996) found significant increases only in noradrenaline, with dopamine and adrenaline increases not reaching statistical significance. Evidence for a multi-hour sustained post-immersion elevation in both dopamine and adrenaline is therefore overstated.
The anterior midcingulate cortex increases in volume or connectivity when people engage in difficult behaviors they actively dislike or do not want to do, such as dieting or unwanted cardio exercise.
"So, this anterior midcingulate cortex, turns out, hypertrophies—well, it grows in volume per maybe in number of connections, etc. Number of neurons, maybe, but certainly grows in volume when people successfully diet, when they take their existing exercise program and just add three 30-minute sessions of cardio—but here's the caveat: if they hate cardio." (said at 1:45:27)
The anterior midcingulate cortex (aMCC) is widely recognized as a critical hub for tenacity, cost-benefit valuation, allostatic regulation, and cognitive control under challenging conditions (such as effortful exertion or resisting immediate rewards). Correlational and cross-sectional neuroimaging studies show preserved aMCC cortical thickness in 'superagers' and structural differences across various clinical and lifestyle cohorts. However, the specific claim that the aMCC increases in volume or connectivity specifically as a direct result of engaging in tasks one 'actively dislikes' is a theoretical extrapolation of neuroscientific models of tenacity and allostasis rather than a demonstrated causal finding from intervention trials.
- context: Youthful Brains in Older Adults: Preserved Neuroanatomy in the Default Mode and Salience N… (The Journal of neuroscience : the official journal of the Society for Neuroscience 2016)
"Building on prior research showing that cortical thickness in one brain region, the anterior midcingulate cortex, is preserved in older adults with memory performance abilities equal to or better than those of people 20-30 years younger (i.e., 'superagers'), we examined the structural integrity of two large-scale intrinsic brain networks in superaging..." (abstract, results, passage verified)
pubmedfull study (doi) - context: The tenacious brain: How the anterior mid-cingulate contributes to achieving goals. (Cortex; a journal devoted to the study of the nervous system and behavior 2020)
"We review evidence from non-human primate neuroanatomy and structural and functional neuroimaging in humans suggesting that the anterior mid cingulate cortex (aMCC) is an important network hub in the brain that performs the cost/benefit computations necessary for tenacity. Specifically, we propose that its position as a structural and functional hub allows the aMCC to integrate signals from diverse brain systems to predict energy requirements that are needed for attention allocation, encoding of new information, and physical movement, all in the service of goal attainment." (abstract, results, passage verified)
pubmedfull study (doi) - context: Motivation in the Service of Allostasis: The Role of anterior Mid Cingulate Cortex. (Advances in motivation science 2019)
"We outline a system of brain networks that have been shown to be important for motivation, and focus in on one hub in this network, the anterior mid-cingulate cortex (aMCC), and discuss its importance for establishing motivation in the service of allostasis." (abstract, results, passage verified)
pubmedfull study (doi)
Red light, near-infrared, and infrared light therapy promote faster muscle recovery, improve skin health and acne, accelerate wound healing, reduce pain and inflammation, enhance mitochondrial function, and improve vision.
"red light, near-infrared, and infrared light have been specifically shown to have positive effects on improving numerous aspects of cellular and organ health. These include faster muscle recovery, improved skin health, wound healing, improvements in acne, reduced pain and inflammation, improved mitochondrial function, and even improvements in vision." (said at 1:48:00)
Photobiomodulation (PBM) utilizing red and near-infrared (NIR) wavelengths is biologically hypothesized to act on mitochondrial cytochrome c oxidase and cellular redox signaling. Systematic reviews and clinical trials show modest or preliminary evidence for pain reduction, modulation of inflammatory markers in muscle recovery, and wound healing. However, sweeping claims that light therapy universally improves vision, skin health, muscle recovery, and inflammation across general populations overstate the current clinical evidence base, which is limited by high protocol heterogeneity, small sample sizes, dose-dependency, and variable methodological quality.
- partial: Photobiomodulation in chronic pain: a systematic review of randomized clinical trials. (Frontiers in integrative neuroscience 2026)
"Most trials demonstrated significant pain reduction with PBM, particularly in fibromyalgia and neuropathy. In some studies, functional gains and improved quality of life were observed... However, the variability of clinical parameters and limited follow-up still hinder more comprehensive recommendations." (abstract, results and conclusions)
pubmedfull study (doi) - partial: Effects of photobiomodulation on inflammatory factors during skeletal muscle regeneration:… (Photochemistry and photobiology 2026)
"The results show that PBM treatment reduces levels of tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, and IL-6 during skeletal muscle regeneration, especially in the early stage of skeletal muscle injury (6 and 12 h)... In conclusion, PBM therapy primarily reduces inflammatory factor levels in the early stage of skeletal muscle injury, thereby accelerating skeletal muscle regeneration." (abstract, results and conclusions)
pubmedfull study (doi) - partial: Clinical dosimetry and efficacy of LED photobiomodulation for chronic lower-limb wound hea… (Lasers in medical science 2026)
"The overall certainty of the evidence, assessed using the GRADE approach, was classified as very low due to inconsistency and indirectness among the included studies. Although LED photobiomodulation appears to be safe and demonstrates therapeutic potential, substantial heterogeneity in irradiation parameters, small sample sizes, and methodological limitations preclude definitive conclusions regarding its clinical efficacy." (abstract, results and conclusions, passage verified)
pubmedfull study (doi) - partial: Photobiomodulation in Age-Related Macular Degeneration: A Mitochondrial Bioenergetic Frame… (Life (Basel, Switzerland) 2026)
"Experimental studies indicate that PBM may influence mitochondrial activity through multiple mechanisms, including modulation of cytochrome c oxidase, nitric oxide photodissociation, and redox signaling pathways. However, the diversity of mechanisms and variability of clinical outcomes suggest that the biological basis of PBM remains incompletely understood." (abstract, results, passage verified)
pubmedfull study (doi)
Medically supervised use of ibogaine can successfully treat addiction and PTSD in veterans.
"The arc of both successful escape from addiction and PTSD or whatever you want to call it through the proper use of ibogaine, medically supervised" (said at 2:13:18)
The claim overstates the current level of scientific evidence. While preliminary prospective observational studies in military veterans (specifically Special Operations Forces veterans treated in clinic settings in Mexico) have demonstrated substantial reductions in PTSD symptoms, depression, and alcohol misuse following medically supervised magnesium-ibogaine protocols, these studies are open-label, non-randomized, uncontrolled, and often involve co-administration of other substances (such as 5-MeO-DMT). Rigorous, randomized controlled trials are still needed to establish efficacy and safety.
- partial: Open-label study of consecutive ibogaine and 5-MeO-DMT assisted-therapy for trauma-exposed… (The American journal of drug and alcohol abuse 2023)
"There were significant and large improvements in self-reported PTSD symptoms ( p < .001, d = .414), depression ( p < .001, d = .275), anxiety ( p < .001, d = .276)... Conclusions: Data suggest combined ibogaine and 5-MeO-DMT assisted therapy has potential to provide rapid and robust changes in mental health functioning with a signal of durable therapeutic effects up to 6-months. Future research in controlled settings is warranted." (abstract, results)
pubmedfull study (doi) - partial: Magnesium-ibogaine therapy in veterans with traumatic brain injuries. (Nature medicine 2024)
"In the present study, we report a prospective observational study of the Magnesium-Ibogaine: the Stanford Traumatic Injury to the CNS protocol (MISTIC), provided together with complementary treatment modalities, in 30 male SOVs with predominantly mild TBI... MISTIC resulted in significant improvements in functioning both immediately (P corrected < 0.001, Cohen's d = 0.74) and 1 month (P corrected < 0.001, d = 2.20) after treatment and in PTSD (P corrected < 0.001, d = 2.54)... Controlled clinical trials to assess safety and efficacy are needed to validate these initial open-label findings." (abstract, results, passage verified)
pubmedfull study (doi) - partial: Prospective associations of psychedelic treatment for co-occurring alcohol misuse and post… (Military psychology : the official journal of the Division of Military Psychology, American Psychological Association 2024)
"There was a significant reduction in alcohol use from pre-treatment (M = 7.2, SD = 2.3) to 1 m (M = 3.6; SD = 3.5) post-treatment, which remained reduced through 6 m... Given these findings, future clinical trials should determine whether psychedelic-assisted therapy holds promise for individuals with complex trauma and alcohol misuse who have not been successfully treated with traditional interventions." (abstract, results)
pubmedfull study (doi)
Overcoming resistance or making the harder choice provides opportunities to increase the size of the anterior mid-cingulate cortex.
"But look, it's just all more opportunities to grow your anterior mid-cingulate cortex size." (said at 2:34:44)
The anterior mid-cingulate cortex (aMCC) has been proposed in theoretical review papers (e.g., Touroutoglou et al., 2020) as a critical hub integrating metabolic and reward signals to estimate the cost of effort and sustain goal-directed tenacity. However, claims that actively overcoming resistance or making harder choices directly increases the physical size/volume of the aMCC via neuroplasticity are overstated extrapolation from theoretical models, cross-sectional neuroimaging, and correlational neuroanatomy rather than prospectively demonstrated causal increases in human structural brain volume.
The brain learns and undergoes neuroplastic changes primarily through friction and failure rather than through successful performance.
"This is how the brain learns. The brain learns by experiencing friction. It doesn't learn by experiencing performance. I mean, we don't learn from performance. We only learn from failure, right? That the brain won't change unless it has to change." (said at 0:41:45)
The claim overstates the primacy of errors and failure in learning. While sensory prediction errors and discrepancy detection are well-established drivers of rapid adaptation (particularly in cerebellar circuits), the brain equally relies on reward-based reinforcement learning, dopaminergic signaling, and use-dependent plasticity to consolidate and retain successful behaviors. Both error processing and successful performance are complementary, essential components of neuroplasticity and skill acquisition rather than failure operating as the primary mechanism over success.
- context: Neural signatures of reward and sensory error feedback processing in motor learning. (Journal of neurophysiology 2019)
"At least two distinct processes have been identified by which motor commands are adapted according to movement-related feedback: reward-based learning and sensory error-based learning. In sensory error-based learning, mappings between sensory targets and motor commands are recalibrated according to sensory error feedback. In reward-based learning, motor commands are associated with subjective value, such that successful actions are reinforced." (abstract, results, passage verified)
pubmedfull study (doi) - context: New roles for dopamine in motor skill acquisition: lessons from primates, rodents, and son… (Journal of neurophysiology 2021)
"Dopamine, a neuromodulator with a multifaceted role in synaptic plasticity, may be a key signaling molecule for motor skill learning. Though typically studied in the context of reward-based associative learning, dopamine appears to be necessary for some types of motor learning." (abstract, passage verified)
pubmedfull study (doi) - context: Mechanisms of Human Motor Learning Do Not Function Independently. (Frontiers in human neuroscience 2021)
"Human motor learning is governed by a suite of interacting mechanisms each one of which modifies behavior in distinct ways and rely on different neural circuits. In recent years, much attention has been given to one type of motor learning, called motor adaptation. Here, the field has generally focused on the interactions of three mechanisms: sensory prediction error SPE-driven, explicit (strategy-based), and reinforcement learning." (abstract, passage verified)
pubmedfull study (doi)
In order to wake up feeling refreshed and energized, human body temperature must increase by approximately 1 to 3 degrees Fahrenheit.
"And in order to wake up feeling refreshed and energized, your body temperature actually has to increase by about 1 to 3°." (said at 1:14:55)
Core body temperature follows an endogenous circadian rhythm where the lowest point (nadir) occurs during the second half of the nocturnal sleep period, after which temperature begins to rise leading into morning awakening and daytime alertness. However, claiming that body temperature must rise by '1 to 3 degrees Fahrenheit' to wake up refreshed overstates the magnitude: the entire 24-hour peak-to-trough circadian amplitude of human core body temperature is typically only about 0.5 °C to 1.0 °C (~0.9 °F to 1.8 °F), and only a portion of that change occurs immediately around waking.
Acute exercise causes circulating cortisol levels to increase by at least fourfold during and after a workout.
"when you exercise, and you probably quadruple your cortisol levels at least during the workout and and afterwards, depending on the workout." (said at 1:41:50)
While moderate-to-high intensity acute exercise stimulates the hypothalamic-pituitary-adrenal axis and increases circulating cortisol, the magnitude and consistency of the response are substantially overstated. Controlled exercise trials demonstrate that cortisol elevations are intensity-dependent, generally occurring above ~60% of VO2max. At high intensities (such as 80% VO2max), cortisol typically increases by approximately 40% to 83% (less than a 2-fold increase), far below the claimed 'at least fourfold' (400%) increase. Furthermore, low-intensity exercise produces minimal changes or even slight decreases in circulating cortisol after adjusting for plasma volume and circadian rhythms, and levels typically return to or drop below baseline within a few hours post-exercise.
- contradicts: Exercise and circulating cortisol levels: the intensity threshold effect. (Journal of endocrinological investigation 2008)
"The percent change in cortisol from pre- to post-sampling at each session was: resting-control, 40, 60, and 80% sessions (mean+/-SD) =-6.6+/-3.5%, +5.7+/-11.0%, +39.9+/-11.8%, and +83.1+/-18.5%, respectively." (abstract, results, passage verified)
pubmedfull study (doi) - partial: Steroid hormone responses to three exercise modalities assessed by liquid chromatography t… (Scientific reports 2026)
"Only HIIE elevated cortisol (P < 0.001) and cortisone (P < 0.01) post-exercise, while cortisol fell below rest at 2 h across all modalities (P < 0.001)." (abstract, results)
pubmedfull study (doi)
In order to wake up feeling refreshed and energized, human body temperature must increase by approximately 1 to 3 degrees.
"And in order to wake up feeling refreshed and energized, your body temperature actually has to increase by about 1 to 3°." (said at 0:18:31)
Core body temperature (CBT) follows an endogenous circadian rhythm that reaches its nadir (Tmin) in the latter half of the nocturnal sleep episode and rises leading into and following morning awakening, a phase closely linked to waking alertness and the dissipation of sleep inertia. However, claiming that CBT 'must increase by approximately 1 to 3 degrees' to wake up refreshed is overstated: the total 24-hour peak-to-trough amplitude of the human core temperature rhythm is typically only ~0.5 °C to 1.0 °C (~1 °F to 2 °F), and feeling refreshed depends on multifaceted circadian, homeostatic, and sleep architecture factors rather than a mandatory multi-degree core temperature surge.
- partial: Individual differences in the phase and amplitude of the human circadian temperature rhyth… (Journal of sleep research 2000)
"The Tmin occurred at approximately the middle of the 8-h sleep period, but it occurred closer to wake in subjects with later Tmin values and increasing eveningness. In other words, E-types slept on an earlier part of their temperature cycle than M-types. This difference in the phase-relationship between temperature and sleep may explain why E-types are more alert at bedtime and sleepier after waking than M-types." (abstract, results, passage verified)
pubmedfull study (doi) - context: An endogenous circadian rhythm in sleep inertia results in greatest cognitive impairment u… (Journal of biological rhythms 2008)
"This revealed a significant circadian rhythm in the sleep inertia of cognitive performance (p = 0.007), which was 3.6 times larger during the biological night (circadian bin 300 degrees , approximately 2300-0300 h in these subjects) than during the biological day (bin 180 degrees , approximately 1500-1900 h)." (abstract, results, passage verified)
pubmedfull study (doi) - context: Skin temperature, sleep, and vigilance. (Handbook of clinical neurology 2018)
"A large number of studies have shown a close association between the 24-hour rhythms in core body temperature and sleep propensity." (abstract, results, passage verified)
pubmedfull study (doi)
Yerba mate provides health benefits including blood sugar regulation, improved digestion, and mild appetite suppression.
"It provides smooth energy without giving you the jitters, and it has a lot of other potential benefits, including helping to regulate your blood sugar, improving digestion, mild appetite suppression, and much more." (said at 1:46:44)
Evidence supports modest effects of yerba mate on glycemic markers and short-term appetite suppression, but clinical evidence for 'improved digestion' is lacking, and trials frequently report gastrointestinal discomfort as an adverse effect. A 2025 meta-analysis of randomized controlled trials found yerba mate significantly reduced postprandial glucose and HbA1c in individuals with pre-diabetes, though fasting glucose was unchanged and overall trial numbers were very small. Small randomized trials and systematic reviews also report short-term decreases in appetite ratings and ghrelin levels. However, digestive benefits remain largely unproven in humans.
- supports: Yerba Maté (Ilex paraguariensis) Metabolic, Satiety, and Mood State Effects at Rest a… (Nutrients 2017)
"VAS scores for hunger, prospective eating, and desire to eat were all reduced ( p < 0.05)." (abstract, results)
pubmedfull study (doi) - supports: Herbal medicines for suppressing appetite: A systematic review of randomized clinical tria… (Complementary therapies in medicine 2019)
"while 6 studies on Ilex paraguariensis, Spinacia oleracea, Phaseolus vulgaris, Secale cereale, Sorghum bicolor and Plantago showed short-term evidence for suppressing appetite." (abstract, results, passage verified)
pubmedfull study (doi) - context: Physiological effects of yerba maté (Ilex paraguariensis): a systematic review. (Nutrition reviews 2023)
"Studies showed consistent effects of yerba maté intake on metabolism improvement and antioxidant and anti-inflammatory activities in different populations. Benefits for body weight and composition, exercise performance, mood, and appetite, in addition cardio- and neuroprotective effects, were also observed. Risk of bias was categorized as high in 22 studies, moderate in 9 studies, and low in 1 study. The certainty of evidence ranged from moderate to very low." (abstract, results)
pubmedfull study (doi) - partial: Yerba Maté and its impact on glycemic control and metabolic health: a systematic revi… (Frontiers in endocrinology 2025)
"The results with pre-diabetes patients suggest significant decreases in postprandial glucose (MD -12.76, 95% CI -16.78, -8.74; N = 2), HbA1c (MD -0.37, 95% CI -0.56, -0.18; N = 2), and the homeostatic model assessment index (HOMA index) (MD -0.24, 95% CI -0.37, -0.11; N = 2), though further research is needed to confirm these findings. No significant effects were found on triglycerides, total cholesterol, HDL-C, LDL-C, fasting glucose, fasting insulin, waist circumference, or BMI. Adverse events included mucosal irritation, insomnia, tachycardia, angina, headache, and gastrointestinal discomfort." (abstract, results, passage verified)
pubmedfull study (doi)
Magnesium L-threonate, theanine, chamomile extract, glycine, saffron, and valerian root are clinically supported ingredients that aid in falling asleep, staying asleep, and waking up refreshed.
"We've known for a long time that there are things that we can do to improve our sleep. And that includes things that we can take. Things like magnesium threonate, theanine, chamomile extract, and glycine. Along with lesser-known things like saffron and valerian root. These are all clinically supported ingredients that can help you fall asleep, stay asleep, and wake up feeling more refreshed." (said at 0:43:00)
While individual randomized trials and meta-analyses suggest potential modest or subjective sleep benefits for ingredients like saffron, magnesium L-threonate, and valerian root, the clinical evidence base across these compounds is mixed, methodologically variable, and often limited to subjective questionnaires rather than consistent objective improvements. Broad systematic and umbrella reviews find that strong empirical support for treating sleep onset, sleep maintenance, and daytime refreshing qualities remains weak or inconclusive.
- contradicts: Does valerian work for insomnia? An umbrella review of the evidence. (European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2024)
"Overall, data suggested that valerian has a good safety profile, however, the results showed no evidence of efficacy for the treatment of insomnia. Moreover, valerian appears to be effective concerning subjective improvement of sleep quality, although its effectiveness has not been demonstrated with quantitative or objective measurements. Despite its widespread use and prescription by general practitioners, psychiatrists and other professionals, valerian does not have empirical support for insomnia." (abstract, results, passage verified)
pubmedfull study (doi) - supports: New horizons for the study of saffron (Crocus sativus L.) and its active ingredients in th… (Phytotherapy research : PTR 2024)
"Saffron was more effective than placebo in improving cognition, depression with an overall effect size of -4.26 (95% CI: -5.76, -2.77), anxiety of -3.75 (95% CI: -5.83, -1.67), and sleep disorders of -1.91 (95% CI: -2.88, -0.93)." (abstract, results, passage verified)
pubmedfull study (doi) - partial: Magnesium-L-threonate improves sleep quality and daytime functioning in adults with self-r… (Sleep medicine: X 2024)
"From subjective questionnaires, MgT significantly (p < 0.05) improved vs placebo behavior upon awakening, energy and daytime productivity, grouchiness, mood and mental alertness." (abstract, results)
pubmedfull study (doi)
Magnesium L-threonate, L-theanine, chamomile extract, and glycine are clinically supported ingredients that can improve sleep latency, sleep maintenance, and morning refreshment.
"And that includes things that we can take, things like magnesium L-threonate, theanine, chamomile extract, and glycine, along with lesser-known things like saffron and valerian root. These are all clinically supported ingredients that can help you fall asleep, stay asleep, and wake up feeling more refreshed." (said at 0:49:48)
While randomized controlled trials and clinical literature exist evaluating magnesium L-threonate, L-theanine, chamomile, and glycine for various aspects of sleep quality, daytime functioning, and relaxation, describing them as uniformly clinically supported across sleep latency, sleep maintenance, and morning refreshment overstates the strength and consistency of the evidence. Human clinical trials on these compounds (particularly magnesium L-threonate and specific botanical/amino acid preparations) are relatively small, often rely on subjective self-reports or consumer wearables, and have yielded mixed results on objective sleep parameters.
- partial: Magnesium-L-threonate improves sleep quality and daytime functioning in adults with self-r… (Sleep medicine: X 2024)
"From subjective questionnaires, MgT significantly (p < 0.05) improved vs placebo behavior upon awakening, energy and daytime productivity, grouchiness, mood and mental alertness." (abstract, results)
pubmedfull study (doi) - partial: An Update of the Promise of Glycine Supplementation for Enhancing Physical Performance and… (Sports (Basel, Switzerland) 2024)
"It is concluded that more randomized controlled clinical trials in humans are needed to confirm glycine's potential as a dietary supplement to support muscle function, recovery, and overall athletic performance as an ergogenic aid and to establish nutritional recommendations for athletic performance." (abstract, conclusions, passage verified)
pubmedfull study (doi) - partial: The effects of magnesium L-threonate (Magtein ® ) on cognitive performance and sleep … (Frontiers in nutrition 2025)
"Based on data from the sleep tracking ring, there were no group differences in sleep outcomes, although there was a greater reduction in HR ( p = 0.030) and an increase in HRV ( p = 0.036), a physiological marker of stress reduction and improved autonomic balance." (abstract, results)
pubmedfull study (doi)
Saffron and valerian root are clinically supported ingredients that can assist with falling asleep, staying asleep, and waking refreshed.
"along with lesser-known things like saffron and valerian root. These are all clinically supported ingredients that can help you fall asleep, stay asleep, and wake up feeling more refreshed." (said at 0:49:58)
While saffron (*Crocus sativus*) and valerian root (*Valeriana officinalis*) have both been evaluated in clinical trials for sleep, describing them broadly as clinically supported for falling asleep, staying asleep, and waking refreshed overstates the strength and consistency of the evidence. Meta-analyses of saffron suggest improvements in subjective sleep quality and duration, but the evidence base is small and graded as very low to moderate quality. For valerian root, systematic reviews and umbrella reviews indicate that clinical evidence is inconsistent and methodologically weak, showing some subjective improvement but no reliable objective evidence for treating insomnia or specific sleep architecture outcomes.
- partial: Valerian Root in Treating Sleep Problems and Associated Disorders-A Systematic Review and … (Journal of evidence-based integrative medicine 2020)
"Valerian ( Valeriana officinalis L.) is a popular herbal medicine used as a sleep aid, however the outcomes of previous clinical studies are inconsistent. This study was conducted to update and re-evaluate the available data in order to understand the reason behind the inconsistent outcomes and to provide a broader view of the use of valerian for associated disorders." (abstract, results, passage verified)
pubmedfull study (doi) - partial: Crocus Sativus for Insomnia: A Systematic Review and Meta-Analysis. (International journal of environmental research and public health 2022)
"Crocus sativus reduced insomnia severity (SMD: 0.53; 95%CI: -0.05 to 1.11; I 2 statistic = 59%; p = 0.08) and increased sleep quality (SMD 0.89, 95% CI 0.10 to 1.68; I 2 statistic = 90%; p = 0.03; 6 studies, 308 participants, very low-quality evidence) and duration (SMD: 0.57; 95%CI: 0.21 to 0.93; I 2 statistic = 40%; p = 0.002; 5 studies; 220 participants, moderate-quality evidence) compared with the placebos. Although there is limited evidence of a very low- to moderate-quality, Crocus sativus may benefit people with insomnia." (abstract, results, passage verified)
pubmedfull study (doi) - contradicts: Does valerian work for insomnia? An umbrella review of the evidence. (European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2024)
"Overall, data suggested that valerian has a good safety profile, however, the results showed no evidence of efficacy for the treatment of insomnia. Moreover, valerian appears to be effective concerning subjective improvement of sleep quality, although its effectiveness has not been demonstrated with quantitative or objective measurements. Despite its widespread use and prescription by general practitioners, psychiatrists and other professionals, valerian does not have empirical support for insomnia." (abstract, results, passage verified)
pubmedfull study (doi)
The pressure on researchers to publish landmark papers in top-tier journals is one of the primary drivers of scientific fraud.
"Actually, that's one of the major causes of scientific fraud, by the way, when people feel that their papers have to be published in the top tier journals. It's probably the strongest driver of scientific fraud." (said at 1:06:11)
Although the belief that publication pressure drives scientific misconduct is widespread among researchers and higher-impact journals show higher retraction rates, large-scale empirical matched-control studies have largely failed to support 'pressure to publish' as a universal primary driver of fraud. Instead, empirical analyses indicate that documented misconduct (such as data fabrication, falsification, and problematic image duplication) is primarily predicted by structural factors such as direct cash rewards for publication, absence of institutional integrity policies, early career stage, and lack of peer scrutiny, while showing null or inverse associations with publication pressure in Western academic systems.
- context: Retracted science and the retraction index. (Infection and immunity 2011)
"Using a novel measure that we call the "retraction index," we found that the frequency of retraction varies among journals and shows a strong correlation with the journal impact factor." (abstract, results, passage verified)
pubmedfull study (doi) - contradicts: Misconduct Policies, Academic Culture and Career Stage, Not Gender or Pressures to Publish… (PloS one 2015)
"the widespread belief that pressures to publish are a major driver of misconduct was largely contradicted: high-impact and productive researchers, and those working in countries in which pressures to publish are believed to be higher, are less-likely to produce retracted papers, and more likely to correct them." (abstract, results, passage verified)
pubmedfull study (doi) - contradicts: Testing Hypotheses on Risk Factors for Scientific Misconduct via Matched-Control Analysis … (Science and engineering ethics 2019)
"Results of univariable and multivariable analyses support the hypotheses that academic culture, peer control, cash-based publication incentives and national misconduct policies might affect scientific integrity. No clear support was found for the "pressures to publish" hypothesis." (abstract, results, passage verified)
pubmedfull study (doi) - context: Do individual and institutional predictors of misconduct vary by country? Results of a mat… (PloS one 2022)
"In particular, in countries where publications are rewarded with cash incentives, and especially China, the risk of problematic image duplication was higher for more productive, more frequently cited, earlier-career researchers working in lower-ranking institutions, in accordance with a "misaligned incentives" explanation for scientific misconduct. However, a null or opposite pattern was observed in all other countries, and especially the USA, UK and Canada, countries where concerns for misaligned incentives are commonly expressed." (abstract, results, passage verified)
pubmedfull study (doi)
Dopamine neural circuitry operates such that following a major success, subsequent achievements will not feel rewarding unless they surpass the magnitude of the prior event.
"Dopamine dynamics in the brain would tell us that if you have a big success, say a book or a movie or an album, what have you, that the next thing, no matter how well it goes, is not going to feel that great unless it exceeds the previous thing. This is just the laws of dopamine circuitry that exist in all of us." (said at 1:27:13)
The claim oversimplifies and exaggerates the principles of dopaminergic reward prediction error (RPE) and adaptive coding. Midbrain dopamine neurons encode the difference between received rewards and predicted outcomes (positive prediction errors for better-than-expected outcomes, baseline for fully predicted outcomes, and negative prediction errors for worse-than-expected outcomes). While expectations dynamically update and dopamine neurons rescale their dynamic range to context and reward distributions, this adaptive coding allows the dopamine system to maintain sensitivity to smaller rewards across changing contexts, rather than permanently setting an absolute threshold where no subsequent achievement feels rewarding unless it exceeds a prior peak magnitude.
- contradicts: Adaptive coding of reward value by dopamine neurons. (Science (New York, N.Y.) 2005)
"Responses shifted relative to the expected reward value, and the gain adjusted to the variance of reward value. In this way, dopamine neurons maintained their reward sensitivity over a large range of reward values." (abstract, results, passage verified)
pubmedfull study (doi) - context: Dopamine reward prediction error coding. (Dialogues in clinical neuroscience 2016)
"Most dopamine neurons in the midbrain of humans, monkeys, and rodents signal a reward prediction error; they are activated by more reward than predicted (positive prediction error), remain at baseline activity for fully predicted rewards, and show depressed activity with less reward than predicted (negative prediction error)." (abstract, results, passage verified)
pubmedfull study (doi) - context: Dopamine Modulates Adaptive Prediction Error Coding in the Human Midbrain and Striatum. (The Journal of neuroscience : the official journal of the Society for Neuroscience 2017)
"Learning to optimally predict rewards requires agents to account for fluctuations in reward value. Recent work suggests that individuals can efficiently learn about variable rewards through adaptation of the learning rate, and coding of prediction errors relative to reward variability." (abstract, results, passage verified)
pubmedfull study (doi)
Fact-checked episodes
Publications
- Virtual reality stimulation for neuroprotection and neuroenhancement of vision in optic neuropathy patients: a prospective clinical trial.BMC ophthalmology 2025 · CEBM Level 4
- Neurotoxic Reactive Astrocytes Drive Neuronal Death after Retinal Injury.Cell reports 2024 · CEBM Level 5
- Corrigendum to "Characterization of non-alpha retinal ganglion cell injury responses reveals a possible block to restoring ipRGC function".Experimental neurology 2023 · CEBM Level 5
- Brief structured respiration practices enhance mood and reduce physiological arousal.Cell reports. Medicine 2023 · CEBM Level 2
- Postsynaptic neuronal activity promotes regeneration of retinal axons.Cell reports 2023 · CEBM Level 5
- Thalamus: Then and now.The Journal of comparative neurology 2022 · CEBM Level 5
- Central nervous system regeneration.Cell 2022 · CEBM Level 5
- Characterization of non-alpha retinal ganglion cell injury responses reveals a possible block to restoring ipRGC function.Experimental neurology 2022 · CEBM Level 5
- Human Responses to Visually Evoked Threat.Current biology : CB 2021 · CEBM Level 4
- Divergent outputs of the ventral lateral geniculate nucleus mediate visually evoked defensive behaviors.Cell reports 2021 · CEBM Level 5
- Neuroscience: A Chromatic Retinal Circuit Encodes Sunrise and Sunset for the Brain.Current biology : CB 2020 · CEBM Level 5
- Neurotoxic Reactive Astrocytes Drive Neuronal Death after Retinal Injury.Cell reports 2020 · CEBM Level 5
- Sight restored by turning back the epigenetic clock.Nature 2020 · CEBM Level 5
- Sub-topographic maps for regionally enhanced analysis of visual space in the mouse retina.The Journal of comparative neurology 2019 · CEBM Level 5
- Molecular Fingerprinting of On-Off Direction-Selective Retinal Ganglion Cells Across Species and Relevance to Primate Visual Circuits.The Journal of neuroscience : the official journal of the Society for Neuroscience 2019 · CEBM Level 5
- Dedication of Retinal Special Issue to: Harvey J. Karten, M.D.The Journal of comparative neurology 2019 · CEBM Level 5
- Introduction to retinal special issue I.The Journal of comparative neurology 2019 · CEBM Level 5
- Fear: It's All in Your Line of Sight.Current biology : CB 2019 · CEBM Level 5
- Ben Barres (1954-2017).Nature 2018 · CEBM Level 5
- A midline thalamic circuit determines reactions to visual threat.Nature 2018 · CEBM Level 5
- Assembly and repair of eye-to-brain connections.Current opinion in neurobiology 2018 · CEBM Level 5
- Synaptic Convergence Patterns onto Retinal Ganglion Cells Are Preserved despite Topographic Variation in Pre- and Postsynaptic Territories.Cell reports 2018 · CEBM Level 5
- An Unbiased View of Neural Networks: More than Meets the Eye.Neuron 2018 · CEBM Level 5
- Ben Barres (1954-2017).Nature 2018 · CEBM Level 5
- Signal Integration in Thalamus: Labeled Lines Go Cross-Eyed and Blurry.Neuron 2017 · CEBM Level 5
- Regenerating optic pathways from the eye to the brain.Science (New York, N.Y.) 2017 · CEBM Level 5
- Architecture, Function, and Assembly of the Mouse Visual System.Annual review of neuroscience 2017 · CEBM Level 5
- Uniformity from Diversity: Vast-Range Light Sensing in a Single Neuron Type.Cell 2017 · CEBM Level 5
- Strict Independence of Parallel and Poly-synaptic Axon-Target Matching during Visual Reflex Circuit Assembly.Cell reports 2017 · CEBM Level 5
- Life goes by: a visual circuit signals perceptual-motor mismatch.Nature neuroscience 2016 · CEBM Level 5
- Neural activity promotes long-distance, target-specific regeneration of adult retinal axons.Nature neuroscience 2016 · CEBM Level 5
- Cortico-fugal output from visual cortex promotes plasticity of innate motor behaviour.Nature 2016 · CEBM Level 5
- Characteristic patterns of dendritic remodeling in early-stage glaucoma: evidence from genetically identified retinal ganglion cell types.The Journal of neuroscience : the official journal of the Society for Neuroscience 2015 · CEBM Level 5
- Functional assembly of accessory optic system circuitry critical for compensatory eye movements.Neuron 2015 · CEBM Level 5
- Contactin-4 mediates axon-target specificity and functional development of the accessory optic system.Neuron 2015 · CEBM Level 5
- Cortical Cliques: A Few Plastic Neurons Get All the Action.Neuron 2015 · CEBM Level 5
- When Visual Circuits Collide: Motion Processing in the Brain.Cell 2015 · CEBM Level 5
- Cell type-specific manipulation with GFP-dependent Cre recombinase.Nature neuroscience 2015 · CEBM Level 5
- Blindness: Assassins of eyesight.Nature 2015 · CEBM Level 5
- Contributions of Retinal Ganglion Cells to Subcortical Visual Processing and Behaviors.Annual review of vision science 2015 · CEBM Level 5
- Retinal ganglion cell maps in the brain: implications for visual processing.Current opinion in neurobiology 2014 · CEBM Level 5
- Dendritic and axonal targeting patterns of a genetically-specified class of retinal ganglion cells that participate in image-forming circuits.Neural development 2014 · CEBM Level 5
- Visual circuits: mouse retina no longer a level playing field.Current biology : CB 2014 · CEBM Level 5
- A dedicated circuit links direction-selective retinal ganglion cells to the primary visual cortex.Nature 2014 · CEBM Level 5
- Birthdate and outgrowth timing predict cellular mechanisms of axon target matching in the developing visual pathway.Cell reports 2014 · CEBM Level 5
- So many pieces, one puzzle: cell type specification and visual circuitry in flies and mice.Genes & development 2014 · CEBM Level 5
- Transsynaptic tracing with vesicular stomatitis virus reveals novel retinal circuitry.The Journal of neuroscience : the official journal of the Society for Neuroscience 2013 · CEBM Level 5
- Diverse visual features encoded in mouse lateral geniculate nucleus.The Journal of neuroscience : the official journal of the Society for Neuroscience 2013 · CEBM Level 5
- Gap junctions are essential for generating the correlated spike activity of neighboring retinal ganglion cells.PloS one 2013 · CEBM Level 5
- Genetic dissection of retinal inputs to brainstem nuclei controlling image stabilization.The Journal of neuroscience : the official journal of the Society for Neuroscience 2013 · CEBM Level 5
- Visual cognition: rats compare shapes among the crowd.Current biology : CB 2012 · CEBM Level 5
- Wiring visual circuits, one eye at a time.Nature neuroscience 2012 · CEBM Level 5
- The Down syndrome critical region regulates retinogeniculate refinement.The Journal of neuroscience : the official journal of the Society for Neuroscience 2011 · CEBM Level 5
- Transgenic mice reveal unexpected diversity of on-off direction-selective retinal ganglion cell subtypes and brain structures involved in motion processing.The Journal of neuroscience : the official journal of the Society for Neuroscience 2011 · CEBM Level 5
- Pathway-specific genetic attenuation of glutamate release alters select features of competition-based visual circuit refinement.Neuron 2011 · CEBM Level 5
- What can mice tell us about how vision works?Trends in neurosciences 2011 · CEBM Level 5
- Cadherin-6 mediates axon-target matching in a non-image-forming visual circuit.Neuron 2011 · CEBM Level 5
- The developmental remodeling of eye-specific afferents in the ferret dorsal lateral geniculate nucleus.Anatomical record (Hoboken, N.J. : 2007) 2010 · CEBM Level 5
- Molecular and cellular mechanisms of lamina-specific axon targeting.Cold Spring Harbor perspectives in biology 2010 · CEBM Level 5
- Milestones and mechanisms for generating specific synaptic connections between the eyes and the brain.Current topics in developmental biology 2010 · CEBM Level 5
- Emergence of lamina-specific retinal ganglion cell connectivity by axon arbor retraction and synapse elimination.The Journal of neuroscience : the official journal of the Society for Neuroscience 2010 · CEBM Level 5
- Genetic identification of an On-Off direction-selective retinal ganglion cell subtype reveals a layer-specific subcortical map of posterior motion.Neuron 2009 · CEBM Level 5
- Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis.Cell 2009 · CEBM Level 5
- Mammalian DSCAMs: they won't help you find a partner, but they'll guarantee you some personal space.Neuron 2009 · CEBM Level 5
- Mechanisms underlying development of visual maps and receptive fields.Annual review of neuroscience 2008 · CEBM Level 5
- Architecture and activity-mediated refinement of axonal projections from a mosaic of genetically identified retinal ganglion cells.Neuron 2008 · CEBM Level 5
- Mechanisms of eye-specific visual circuit development.Current opinion in neurobiology 2007 · CEBM Level 5
- The classical complement cascade mediates CNS synapse elimination.Cell 2007 · CEBM Level 5
- Target-derived cues instruct synaptic differentiation.The Journal of neuroscience : the official journal of the Society for Neuroscience 2006 · CEBM Level 5
- Nob mice wave goodbye to eye-specific segregation.Neuron 2006 · CEBM Level 5
- Dynamics of spontaneous activity in the fetal macaque retina during development of retinogeniculate pathways.The Journal of neuroscience : the official journal of the Society for Neuroscience 2006 · CEBM Level 5
- Neuronal pentraxins mediate synaptic refinement in the developing visual system.The Journal of neuroscience : the official journal of the Society for Neuroscience 2006 · CEBM Level 5
- Spontaneous retinal activity mediates development of ocular dominance columns and binocular receptive fields in v1.Neuron 2006 · CEBM Level 5
- Early and rapid targeting of eye-specific axonal projections to the dorsal lateral geniculate nucleus in the fetal macaque.The Journal of neuroscience : the official journal of the Society for Neuroscience 2005 · CEBM Level 5
- Ephrin-As mediate targeting of eye-specific projections to the lateral geniculate nucleus.Nature neuroscience 2005 · CEBM Level 5
- Eye-specific retinogeniculate segregation independent of normal neuronal activity.Science (New York, N.Y.) 2003 · CEBM Level 5
- Crossed and uncrossed retinal projections to the hamster circadian system.The Journal of comparative neurology 2003 · CEBM Level 5
- Decoupling eye-specific segregation from lamination in the lateral geniculate nucleus.The Journal of neuroscience : the official journal of the Society for Neuroscience 2002 · CEBM Level 5
- Neurotrophins and visual cortical plasticity.Progress in brain research 2002 · CEBM Level 5